Dr Bristi Basu is a Clinical Principal Research Associate in the University of Cambridge and Honorary Academic Consultant in Medical Oncology at Cambridge University Hospitals NHS Foundation Trust. Her specialist research focus is in experimental cancer therapeutics, with site specialisation in hepato-pancreatic-biliary tumours. She trained in Medicine at Oxford University (Prosser Exhibitions) before undertaking clinical specialty training in Medical Oncology at Cambridge. During this time, she completed a PhD in cancer cell biology and drug discovery at the University of Cambridge as the Cancer Research UK Gordon Hamilton-Fairley Clinical Research Training Fellow. She has worked as a chief investigator, UK co-ordinating investigator, principal investigator and co-investigator in academic-led and industry-sponsored Phase I, II and III clinical trials, including first-in-human and first-in-class studies. She leads the Cambridge Experimental Cancer Medicine Centre, directs the Cambridge Cancer Trials Centre and co-leads CRUK Cambridge Centre Pancreatic Cancer Programme. She is Chair of the Cancer Research UK Expert Review Panel and Vice-Chair of Cancer Research UK’s Clinical Research Committee. She is Deputy Chair of the UK NCRI Pancreatic Cancer Research group, co-leading its Novel Therapeutics working group, and is a member of the Research Strategy Group for Pancreatic Cancer UK. She works within the Capacity Building leadership team of Cambridge NIHR Biomedical Research Centre and is Director of Studies for Part 2 medical students at Robinson College, Cambridge.